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Abstract
Ultraviolet (UV) light alters cutaneous structure and function. Prior work has shown loss of dermal hyaluronan after UV-
irradiation of human skin, yet UV exposure increases total glycosaminoglycan (GAG) content in mouse models. To more fully
describe UV-induced alterations to cutaneous GAG content, we subjected human volunteers to intermediate-term (5 doses/
week for 4 weeks) or single-dose UV exposure. Total dermal uronyl-containing GAGs increased substantially with each of
these regimens. We found that UV exposure substantially increased dermal content of chondroitin sulfate (CS), but not
hyaluronan, heparan sulfate, or dermatan sulfate. UV induced the accumulation of both the 4-sulfated (C4S) and 6-sulfated
(C6S) isoforms of CS, but in distinct distributions. Next, we examined several CS proteoglycan core proteins and found a
significant accumulation of dermal and endothelial serglycin, but not of decorin or versican, after UV exposure. To examine
regulation in vitro, we found that UVB in combination with IL-1a, a cytokine upregulated by UV radiation, induced serglycin
mRNA in cultured dermal fibroblasts, but did not induce the chondroitin sulfate synthases. Overall, our data indicate that
intermediate-term and single-dose UVB exposure induces specific GAGs and proteoglycan core proteins in human skin in
vivo. These molecules have important biologic functions and contribute to the cutaneous response to UV.
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Introduction
Ultraviolet light is a major environmental source of damage to
skin. A hallmark of chronically photodamaged skin is the induction
of glycosaminoglycans (GAGs) in the dermis [1]. GAGs are
unbranched, polyanionic polysaccharide chains made up of
repeating disaccharide units. The GAGs of normal skin include
chondroitin sulfate (CS), hyaluronic acid (HA), dermatan sulfate
(DS), heparan sulfate (HS), and keratan sulfate [2], each of which
exerts distinct biologic actions. All GAGs, except HA, are
covalently attached to a polypeptide backbone called a core
protein, and the resulting protein-carbohydrate complex is called a
proteoglycan (PG). Much of the GAG content within chronic solar
elastoic lesions consists of CS linked to the versican core protein
[3,4]. However, there has been no systematic study of the
alterations to GAGs or PGs during the early stages of
photodamage in human skin. The SKH-1 hairless mouse has
been used to model the increase in cutaneous GAGs in response to
UV exposure [5,6], but different published reports describe
increases in CS [7], DS [8], HA [8], or HS without an increase
in DS [9]. Moreover, two recent studies indicate that HA actually
decreases in response to acute [10] and chronic [11] UV
irradiation.
In the past, the function of GAGs and proteoglycans was
assumed to be primarily structural. Indeed, GAGs are major
structural components of the skin’s extracellular matrix and
important in storage of water and electrolytes [12,13]. Recent
literature suggests that specific GAGs have roles in inflammatory
processes [14,15].
In the current study, we re-examined the cutaneous response to
UV by determining if short- and intermediate-term UV exposure of
human skin induces accumulation of GAGs, as assessed by Hale
stain, and then used specific antibodies and mRNA probes to
characterize specific molecular species of GAGs and PGs.
Importantly, the responses of human skin during these early periods
have not been previously characterized, nor have the effects of
specific wavelengths of light. Knowledge of the responses of specific
GAGs and PGs to UV could further our understanding of the early
events that lead to photodamage. Therefore, in the current study,
we determined if short- and intermediate-term UV exposure
induced accumulation of GAGs, as assessed by Hale stain, and
then used specific antibodies and mRNA probes to characterize
specific molecular species involved in the response to UV.
Results
Intermediate-term UVB irradiation increases total dermal
GAG content of human skin in vivo
Four weeks of UVB exposure, delivered in five doses per week
to healthy human volunteers, resulted in a striking increase in
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August  4GAG content, indicated by blue staining by Hale, in irradiated
relative to non-irradiated skin. Control skin shows localization of
GAGs below the dermal-epidermal junction (Figure 1a). Epider-
mal GAG staining with Hale was substantially lighter than dermal
staining in both control and UVB-exposed skin, and irradiation
did not significantly change it. Quantitative image analyses
showed that the dermis of UVB-irradiated skin stained 4.9 times
more intensely for GAGs than the dermis of non-irradiated skin
(Figure 1b,c). Visual inspection indicated that the distribution of
dermal GAGs was altered by UVB exposure. In normal tissue,
GAGs are concentrated in the upper dermis close to the dermal-
epidermal junction (Figure 1a). UVB-irradiated skin exhibits
GAGs deeper in the dermis, although they are still most densely
localized directly below the epidermis (Figure 1b). There was no
accumulation of elastosis seen in these intermediate-term irradi-
ation experiments done on non sun-exposed skin (data not shown).
Intermediate-term UVB irradiation of human skin in vivo
does not significantly alter dermal content of HA, DS, or
HS
HA, a uronic acid-containing GAG, was visualized using
biotinylated HA binding protein (HABP), visualized with a
streptavidin horseradish peroxidase system. Normal human skin
displayed HA throughout the dermis (Figure 2a). Dark staining
was evident in the upper epidermis of non-exposed skin, but the
basal layer did not contain much HA. UVB exposure resulted in
HA occupying the basal layer as well as the rest of the epidermis,
with no significant change in the total HA content of the epidermis
(Figure 2b,c). HABP staining in the upper dermis of UVB-exposed
skin was more diffuse than that in the upper dermis of normal skin,
but UVB did not cause significant reduction in the overall dermal
HA content (Figure 2b,c). IHC using a monoclonal anti-HS and
anti-DS antibody showed no UVB induction of HS or DS (data
not shown).
Intermediate-term UVB irradiation increases dermal CS
content of human skin in vivo
Chondroitin sulfate was detected using monoclonal antibody
CS-56, which recognizes C4S and C6S, but not dermatan sulfate.
In normal skin, epidermal staining was variable but typically
present (Figure 3a). The great majority of CS is localized in the
dermis, in a dense band directly below the dermal-epidermal
junction. With chronic UVB exposure, epidermal CS content is
variable and not induced (Figure 3b). UVB irradiation results in
CS content deeper in the dermis, and quantification of dermal
stain intensity shows an increase to nearly three times the
unirradiated controls (Figure 3c). CS staining intensity data for
the epidermis was not included because epidermal staining was
Figure 1. Effect of intermediate-term UVB irradiation on total dermal GAG content of human skin in vivo. Human volunteers were
sham-irradiated or exposed to UVB 5 times weekly for 4 weeks. Biopsies were taken and GAGs were visualized using Hale’s stain. Collagen stains red,
cytoplasm stains yellow, and GAGs stain blue in (a) control skin and (b) UVB-irradiated skin. The images in this figure are of tissue from the same
patient. The GAG stain intensity was quantified using ImagePro version 3 and graphed (c). Sham skin is represented by open bars and UVB-irradiated
skin by solid bars. (size bars=62.5 mm, ***p,.001 versus sham, n=5).
doi:10.1371/journal.pone.0014830.g001
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accumulates in the same locations where blue Hale staining
increases, but HA, HS, and DS do not, CS appears to be largely
responsible for the UVB-induced increase in GAG content of
human skin.
Intermediate-term irradiation of human skin in vivo with
different UV wavelengths increases dermal content of
total GAGs and CS
To determine wavelength specificity, we repetitively exposed
subjects to UVA, UVA1, PUVA, and SSR as well as UVB.
UVB caused the greatest increase over control in total dermal
GAG content as detected by Hale stain, and PUVA was the
only other irradiation method that also produced a significant
increase (Figure 4a). UVB was previously shown to be more
effective than UVA at inducing GAG accumulation in SKH1
hairless mouse skin [16]. To examine specific GAG species, we
found that the HA content of human dermis was not
significantly altered by any treatment (Figure 4b). UVA,
UVA1, and PUVA significantly reduced epidermal HA
(Figure 4b). UVB and SSR caused significant increases of HA
in the basal layer of the epidermis. The amount of dermal CS
was significantly increased over non-irradiated skin by UVB
and by SSR (Figure 4c). CS staining in the epidermis was
generally faint and variable, and did not change significantly
with any UV treatment (Figure 4c).
Single-dose UVB irradiation in vivo alters the HA content
of human skin
Healthy human volunteers were given a single dose of 2X MED of
UVB radiation on the back. Biopsies were taken before (control) and at
1, 2, and 3 days after irradiation. Sections were stained with
biotinylated HABP (Figure 5). At all three time-points after irradiation,
the epidermis stained more extensively. In particular, the basal layer of
the epidermis, which was unstained in control skin (Figure 5a), showed
substantial accumulation of HA after single-dose UVB (Figures 5b,c,d).
In the dermis, HA appears to decrease temporarily at 48 hours
(Figure 5c) and then returned to baseline levels by 72 hours (Figure 5d).
Single-dose UVB irradiation induces CS accumulation in
human dermis in vivo
In unexposed skin, dermal CS is located only in the region just
below the dermal-epidermal junction and in the endothelium of
dermal venules (Figures 3a, 6a). After single-dose UVB exposure,
the quantity of dermal CS increases throughout the 24, 48, and
72 hour time-points, localized largely just below the dermal-
epidermal junction (Figure 6b–d).
Single-dose UVB irradiation of human skin in vivo
induces accumulation of the CS isoforms C4S and C6S,
but in different distributions
In mammals, CS exists most commonly as the 4-sulfated
isoform or the 6-sulfated isoform [17]. Here, we performed
Figure 2. Effect of intermediate-term UVB exposure on dermal HA in vivo. Skin was (a) sham-irradiated or (b) UVB-irradiated 5 times weekly
for 4 weeks. HA was labeled with biotinylated HABP and visualized using a peroxidase system. The images in this figure are of tissue from the same
patient. Stain intensity in dermis, epidermis, and the basal layer of the epidermis was quantified using ImagePro version 3 and graphed (c). Sham skin
is represented by open bars and UVB-irradiated skin by solid bars. (size bars=62.5 mm, *p,.05).
doi:10.1371/journal.pone.0014830.g002
UV Modulates Cutaneous GAGs
PLoS ONE | www.plosone.org 3 e14830 August 2011 | Volume  6  |    Iss    u e   8 |  immunohistochemistry for the C4S isoform on skin sections using
the 2B6 anti-Ddi-4S monoclonal antibody. We found that C4S
was distributed throughout the upper dermis in normal skin
(Figure 7a). From 24 to 72 hours after exposure to single-dose
UVB, C4S accumulated in both the upper and lower dermis
(Figure 7b–d). The other CS isoform, C6S, was detected using the
3B3 anti-Ddi-6S monoclonal antibody. In unexposed control skin,
C6S is present just below the dermal-epidermal junction
(Figure 7e). Following single-dose UVB, C6S accumulated in the
upper dermis and on endothelium, with peak staining at 48 hours
post-irradiation (Figure 7f–h). Studies have indicated that CS-56
antibody has a higher affinity for C6S than C4S, and also binds to
only certain epitopes of CS [18,19], providing an explanation for
differential staining seen with the C4S antibody and CS-56
(Figure 6).
UVB and IL-1a paradoxically suppress chondroitin sulfate
synthase mRNAs in cultured human dermal fibroblasts
Chondroitin polymerization is achieved by combinations of the
three chondroitin sulfate synthases, CSS1, CSS2, CSS3, and
chondroitin-polymerizing factor [20]. To investigate their regula-
tion, we simulated the effects of UVB irradiation in vivo by co-
stimulating cultured dermal fibroblasts with UVB (30 mJ/cm
2)
and IL-1a (1 ng/mL), a cytokine that is released from keratino-
cytes and inflammatory cells in skin upon exposure to UVB. RNA
was extracted 3, 6, and 24 hours after treatment. Levels of mRNA
for the CSS enzymes were quantified with real-time PCR. Despite
the increase in dermal CS seen after UVB irradiation in vivo,
CSS1 mRNA expression was significantly decreased at 3, 6, and
24 hours post-treatment, to 20-40% of control (Figure 8a). CSS2
mRNA showed modest, but significant, suppression at all time-
points 3 and 24 hours post-treatment (Figure 8b). Real-time PCR
revealed a steady decrease in CSS3 mRNA over the time course,
with the treatment suppressing mRNA by 87% at the 24-hour
time point (Figure 8c).
Single-dose UVB irradiation induces dermal serglycin, but
not decorin or versican, and UVB and IL-1a together
induce serglycin mRNA in cultured human dermal
fibroblasts
We next examined the core proteins of CSPGs known to be
present in normal skin, to determine which ones might be
responsible for UVB-induced CS accumulation. Stains for two
major CSPGs of skin, decorin and versican, revealed no significant
changes as a result of intermediate-term UVB irradiation (data not
shown). In unirradiated control skin (Figure 9a), the monoclonal
anti-serglycin antibody stained the epidermis, the endothelium of
dermal venules, and hematopoietic cells. After single-dose UVB
exposure, diffuse upper-dermal staining for serglycin steadily
increased from 24 to 72 hours post-irradiation (Figure 9b–d).
Figure 3. Localization and quantification of CS in human skin following intermediate-term UVB irradiation. Skin was (a) sham-
irradiated or (b) UVB-irradiated 5 times weekly for 4 weeks. CS was labeled with the CS-56 anti-CS antibody and visualized using a biotin-peroxidase
system. The images in this figure are of tissue from the same patient. Stain intensity in the dermis was quantified using ImagePro version 3 and
graphed (c). Sham skin is represented by open bars and UVB-irradiated skin by solid bars. (size bars=62.5 mm, *p,.05).
doi:10.1371/journal.pone.0014830.g003
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irradiation and returned to baseline by 72 hours after exposure.
The number of serglycin-expressing cells in the dermis increased
with time, peaking 48 hours after exposure. The darkly stained
dermal cells correspond to inflammatory cells detected by
hematoxylin and eosin staining. Dermal fibroblasts were co-
stimulated with UVB and IL-1a, as above, and serglycin mRNA
was quantified at 3, 6, and 24 hours after treatment. Treatment
significantly induced serglycin mRNA at 6 and 24 hours post-
exposure, with a more than 2-fold upregulation at the 24 hour
time point (Figure 9e).
Discussion
We found that intermediate-term and single-dose UV irradi-
ation induced highly specific responses in the glycosaminoglycans
and proteoglycan core proteins of human skin. Intermediate-term
UV irradiation, before the development of solar elastosis, caused
dermal accumulation of CS, but not of HA, DS, or HS. We
found that single-dose UV irradiation also induced dermal
accumulation of CS, and two CS isoforms, C4S and C6S, were
induced in distinct distributions. C4S accumulated largely in the
dermis, and C6S largely in the endothelium. Regarding CS
Figure 4. Wavelength-specific effects of intermediate-term irradiation on GAGs, HA, and CS. Normal human volunteers were treated
with sham, UVA, UVA1, PUVA, SSR, and UVB on different sections of their backs 5 times weekly for 4 weeks. ImagePro 3 analysis of treatment-specific
effects were evaluated for (a) total GAG content with Hale stain, (b) HA, and (c) CS. Open bars represent epidermal stain intensity, solid bars represent
dermal stain intensity, and hatched bars represent stain intensity in the basal layer of the epidermis. (***p,.001, **p,.01, *p,.05, n=5 for Figure 4a,
n=4 for Figures 4b-c).
doi:10.1371/journal.pone.0014830.g004
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e14830Figure 5. Time course for changes in HA content of UVB-irradiated skin. Normal human volunteers were exposed to 2X MED of UVB.
Biopsies were taken 1, 2, and 3 days after irradiation. HA was labeled with biotinylated HABP and visualized using a peroxidase system. Shown are
stains of (a) control tissue and tissue taken (b) 24, (c) 48, and (d) 72 hours post-irradiation. The images in this figure are of tissue from the same
patient. (size bars=62.5 mm).
doi:10.1371/journal.pone.0014830.g005
Figure 6. Time course for changes in CS in human skin following single-dose UVB irradiation. Normal human volunteers were exposed to
2X MED of UVB. Biopsies were taken 1, 2, and 3 days after irradiation. CS was labeled with the CS-56 anti-CS antibody and visualized using a biotin-
peroxidase system. Shown are stains of (a) control tissue and tissue taken (b) 24, (c) 48, and (d) 72 hours post-irradiation. The images in this figure are
of tissue from the same patient. (size bars=62.5 mm).
doi:10.1371/journal.pone.0014830.g006
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lation of serglycin, but not of decorin or versican, and the effect
on serglycin could be mimicked in vitro by exposing human
dermal fibroblasts to UVB in combination with IL-1a, a UV-
induced cytokine. Serglycin was reported to have C4S side-chains
when expressed by lymphocytes, platelets, and monocytes [21],
and fibroblasts [22] have serglycin, but it has C6S side-chains
when expressed by endothelial cells [22]. Thus this molecule
could contribute to the accumulation of both C4S in dermis and
C6S in endothelium after UVB exposure.
Figure 7. Effect of a single UVB dose on C4S and C6S in the dermis. Normal human volunteers were exposed to 2X MED of UVB. Biopsies
were taken 1, 2, and 3 days after irradiation. Following enzymatic digestion, C4S was labeled using the 2B6 anti-DDi-4S antibody, and C6S was labeled
with the 3B3 anti-DDi-6S antibody. The stains were developed using a biotin-peroxidase system. Shown are stains of C4S in (a) control tissue and
tissue taken (b) 24, (c) 48, and (d) 72 hours post-irradiation, and of C6S in (e) control tissue and tissue taken (f) 24, (g) 48, and (h) 72 hours post-
irradiation. The images in this figure are of tissue from the same patient. (size bars=62.5 mm).
doi:10.1371/journal.pone.0014830.g007
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other inflammatory stimuli [23,24]. There is evidence that CS
mitigates the inflammatory effects of osteoarthritis [25]. This may
be because it inhibits interleukin-1b induced pro-inflammatory
cascades, as shown in cultured rabbit and human chondrocytes
[26,27]. Moreover, C4S blunts cellular activation by endotoxin
[23] and by small HA fragments [28]. One study that examined
C4S in the absence of other stimuli found activation of immune
cells [14], suggesting that the function depends on the context.
Regarding structural effects, recent studies demonstrated that
CS can inhibit elastogenesis [29,30]. Proteins involved in elastic
fiber synthesis, including fibrillin and DANCE, are strongly
decreased after addition of C4S and after addition of C6S to
cultured fibroblasts [30]. Because CS accumulates after interme-
diate-term UV exposure (Figure 3), short-term UV exposure
(Figure 6), and in late-stage, solar elastotic lesions [4], its early and
sustained induction may contribute to the lack of normal elastic
fibers in chronically irradiated skin.
Surprisingly, although UVB increased CS in human skin, we
found that mRNA levels for CSS1, CSS2, and CSS3 were
paradoxically suppressed by UVB with IL-1a treatment of
fibroblasts in vitro. The same stimuli increased mRNA for the
core protein serglycin, suggesting that CS accumulation is due in
part to increased CS core protein expression. It has been shown
that the overexpression of a PG’s core protein can lead to an
increase in side chain generation, as overexpression of ryudocan,
an HS PG, led to increased HS production [31].
Until recently, serglycin expression was thought to be limited to
hematopoietic cells. Serglycin is secreted by monocytes and
macrophages in response to inflammatory stimuli [21], and
serglycin may also regulate the release of histamine and serotonin
from mast cell granules [32]. Nevertheless, serglycin expression
has been described in chondrocytes [33], and low levels of
serglycin were detected in fibroblasts [22]. In the current study, we
found considerable levels of serglycin expression in dermal
fibroblasts after UV irradiation, suggesting that fibroblast-
synthesized serglycin may be a participant in dermal inflamma-
tion. In endothelial cells, serglycin mRNA is induced by the
inflammatory cytokines TNF-a and IL-1a, suggesting that it may
participate in vascular inflammation as well [22].
Regarding HA, a study by Averbeck et al demonstrated that
UVB increased epidermal HA and decreased dermal HA, and
microdialysis revealed an accompanying accumulation of HA
degradation products in the dermis [10]. Likewise, the reduced
dermal staining we observed at 48 hours post-irradiation could be
due to degradation of HA. Of note, fragmented HA has different
biologic effects than high molecular weight HA. High molecular
weight HA protects against inflammatory and apoptotic signaling
in UVB-exposed corneal epithelial cells [34], and protects against
angiogenesis and immune response [15]. In contrast, fragmented
HA is potently pro-inflammatory and pro-angiogenic. HA
fragments bind to Toll-like receptor 2 and Toll-like receptor 4
on macrophages, stimulating the expression of pro-inflammatory
genes [35], as well as mediating signaling through CD44 in tissue
inflammation [36]. Fragmented HA can also activate immuno-
competent keratinocytes through TLR-2 and TLR4, causing the
release of beta-defensin [37]. Intermediate-term and single-dose
UVB exposure and intermediate-term SSR irradiation induce HA
accumulation in the basal layer of the epidermis (Figures 2, 4, and
5). Further study on the molecular weight and etiology of the HA
that is induced in the basal layer could elucidate its function.
Overall, our findings provide a more complete picture of the
cutaneous response to ultraviolet light, where specific glycosami-
noglycans and proteoglycan core proteins are likely contributors to
cutaneous photodamage and photoaging.
Materials and Methods
Chemicals
Control, non-immune mouse IgG1 antibody was from Becton
Dickinson. All other chemicals were obtained from Fisher
(Pittsburgh, PA) and Sigma (St. Louis, MO).
Figure 8. Effect of UVB +IL-1a on CSS mRNA levels in normal human fibroblasts. Human skin fibroblasts were irradiated with UVB (30 mJ/
cm
2), or sham, 6 IL-1a (1 ng/ml). RNA was extracted with trizol, and CSS1 (a), CSS2 (b), and CSS3 (c) mRNA levels were evaluated using real-time PCR.
(***p,.001, **p,.01).
doi:10.1371/journal.pone.0014830.g008
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In vivo irradiation was performed using an 150-watt xenon arc
solar simulator (Model #16S, Solar Light Company, Phil, PA.)
with a UVB band-pass filter. For in vitro work, the UVB source
was a bank of two FS-40 sunlamps (Lights of America, Walnut,
CA), with a peak irradiance of 313 nm, equipped with a cellulose
triacetate filter to remove wavelengths below 290 nm, as
previously described [38,39]. The light source for UVA and
SSR treatments was a 1000-Watt xenon lamp solar simulator
(Solar Light, Philadelphia, PA), which was used with a UG5
internal filter and an external UG11 filter to remove long
wavelengths and a 3-mm WG335 Schott (UVA) filter to allow
only longer UV wavelengths [39]. UVB doses were measured with
an International Light UV IL-443 UVB meter. UVA and UVA1
doses were verified with an IL 1400 A Research Radiometer
(International Light, Inc., Newburyport, MA). The filtered UVB
light source measured by spectroradiometric measurement at the
time of the experiments showed 0.64% UVC, 44.51% UVB,
19.43% UVA, and 35.42% visible and near infrared (Vis + NIR).
The solar simulator with WG335 Schott filter showed 0.0036%
Figure 9. Induction of serglycin in human skin following single-dose UVB irradiation and in normal human fibroblasts following
stimulation with UVB +IL-1a. Normal human volunteers were exposed to 2X MED of UVB. Biopsies were taken 1, 2, and 3 days after irradiation.
Following enzymatic digestion of CS, serglycin was labeled with the N13 anti-serglycin antibody and visualized using a biotin-peroxidase system.
Shown are stains of (a) control tissue and tissue taken (b) 24, (c) 48, and (d) 72 hours post-irradiation (size bars=62.5 mm). For each, an example of the
endothelium of dermal venules is indicated with an arrow, and an example of a serglycin-positive hematopoietic cell is indicate with an arrow head.
The images in this figure are of tissue from the same patient. Human skin fibroblasts were irradiated with UVB (30 mJ/cm
2), or sham, 6 IL-1a (1 ng/
ml). RNA was extracted with trizol, and serglycin mRNA levels were evaluated using real-time PCR (e). (***p,.001, **p,.01).
doi:10.1371/journal.pone.0014830.g009
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UVA1), 3.35% Vis + NIR.
UV Exposure Protocols
For investigation of chronic irradiation, five human volunteers
with type II skin received UVB, UVA, UVA1, SSR, PUVA, and
sham irradiation to 1 cm
2 spots of sun-protected back skin five
days a week for four weeks. For PUVA treatment, .005% psoralen
gel was applied topically, followed by 1X MED of UVA fifteen
minutes later. Skin was biopsied 24 hours after the last irradiation,
and fixed in formaldehyde. A single-dose time course was also
conducted. Each patient was given a panel of eight 1 cm
2 spots of
UVB radiation in increasing increments of 25% to determine the
MED, the smallest amount of UVB radiation needed to produce
confluent erythema. MED testing was performed on photopro-
tected areas of the mid to lower back. Volunteers were exposed to
a single 2X MED dose of UVB, and skin was sampled and fixed
with formaldehyde 24, 48, and 72 hours post-irradiation. Fixed
tissue was embedded in paraffin wax, and sections were cut onto
slides for chemical stains and IHC. Human skin fibroblasts were
irradiated with UVB (30 mJ/cm
2), or sham, 6 IL-1a (1 ng/ml).
Skin biopsy staining
Biopsies were stained for uronyl-containing acid mucopolysac-
charides using a modification of Mowry’s colloidal iron stain (Hale
stain). Staining to evaluate hyaluronan was done with biotinylated
HABP (0.5 mg/mL, Associates of Cape Cod, East Falmouth, MA)
used at a dilution of 1:100 for chronically irradiated skin samples
and 1:250 for the single dose time course. Negative controls were
achieved by pre-treatment of sections first with 100mM Na acetate
buffer pH 5 for 15 minutes in a 37uC water bath and then with
100 TRU/ml Streptomyces hyalurolyticus hyaluronidase (Sigma, St.
Louis, MO) in 100mM Na acetate buffer pH 5 prior to staining. A
monoclonal mouse antibody for HS was purchased from
Associates of Cape Cod (East Falmouth, MA) and used at a
dilution of 1:400. Negative controls with mouse IgM isotype
control antibody (Sigma, St. Louis, IL) were performed concur-
rently. CS was evaluated using the monoclonal mouse antibody
CS-56 (Sigma, St. Louis, IL), which binds chondroitin A and
chondroitin C. CS-56 antibody was used at a dilution of 1:400 to
stain the intermediate-term irradiated skin sections and at a
dilution of 1:1200 on the skin that had received a single dose of
UVB. Note that a lower anti-CS antibody concentration was used
on the singly-irradiated sections. Binding specificity was confirmed
using negative control sections that were digested with 0.025 unit/
mL Arthobacter aurescens chondroitinase AC in a 50mM acetate
buffer for 90 minutes at pH 6 prior to staining. For DS staining,
sections were pre-treated with 20 mM Tris HCl buffer with
50 mM NaCl, 4 mM CaCl, and 0.01% BSA for 20 minutes at
pH 7.5 and room temperature. Tissue was then digested at room
temperature with Flavobacterium heparinum chondroitinase B (Sigma,
St. Louis, IL) in buffer, and labeled with 2-B-6 anti-Ddi-4S
antibody. The anti-serglycin antibody was N-13, a goat polyclonal
IgG which binds near the N-terminus of human serglycin (Santa
Cruz Biotechnology, Santa Cruz, CA), was used at a concentra-
tion of 10 mg/mL. C-6-S was detected using the 3-B-3 monoclonal
mouse IgM (Associates of Cape Cod, East Falmouth, MA) at a
dilution of 1:100. Both the N-13 anti-serglycin and the 3-B-3 anti-
Ddi-6S antibodies require enzymatic digestion of CS to expose
their antigens. After a 15-minute pre-incubation with BSA-
stabilized Tris-acetate buffer at 37uC and pH 8, samples were
digested with 1 unit/mL Proteus vulgaris chondroitinase ABC
(Sigma) in buffer. Negative controls were achieved by treating
sections with buffer in place of the enzyme. C-4-S was stained
using the 2-B-6 anti-Ddi-4S monoclonal mouse IgM (Associates of
Cape Cod, East Falmouth, MA) at a dilution of 1:600. Slides were
pretreated with ph 6 acetate buffer for 15 minutes at 37uC, then
digested with 025 unit/mL Arthobacter aurescens chondroitinase AC
for antigen exposure prior to treatment with the primary antibody.
Undigested sections were used as negative controls. LSAB+
Biotinylated Link Universal (DAKO, Carpinteria, CA) was used
as the secondary antibody for all IHC stains. Antibodies for CS
and HS, HABP were visualized with the immunoperoxidase
method using the Dakocytomation LSAB+ HRP system from
DAKO (Carpinteria, CA). DS, C-4-S, C-6-S, and Serglycin stains
were developed with the NovaRED system (Vector, Burlingame,
CA). Keratan sulfate, a GAG present in normal human skin, is not
stained by Hale because it does not contain uronic acid.
Therefore, it was not a component of the GAG increase measured
by Hale staining, and was not evaluated.
Quantitation of histology
Stain intensity was quantified using Image Pro Plus version 3.0
Software (MediaCybernetics, Bethesda, MD).
Cultured cells
Normal human fibroblasts were obtained from the American
Type Culture Collection (ATCC, Rockville, MD, catalog
no. 1828X-CRL) and grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal bovine serum.
Extraction of total RNA from cultured fibroblasts
Cells at 60–90% confluency were irradiated with UVB or sham,
followed by addition of cytokines. The viability of cells was
measured by Trypan Blue staining of cells up to 72 hours after
irradiation, and was always greater than 95%. After removal of
medium, cells were washed with phosphate-buffered saline and
total RNA was extracted by adding 1 ml Trizol (Invitrogen,
Carlsbad, CA) directly to the dishes, followed by isopropanol
precipitation and 70% ethanol wash. The RNA pellets were
dissolved in DEPC-treated water. The RNA was quantified by
measuring the optical density at 260 nm, and purity determined
by 260/280 ratio (.1.8).
Real-time PCR
Total RNA (2 g), from sham- or UVB-exposed human
fibroblasts, with or without cytokine addition, was used for cDNA
synthesis. cDNA was synthesized using SUPERSCRIPT First-
Strand Synthesis for reverse transcription–PCR kit with random
hexamers (Invitrogen Life Technologies, Carlsbad, CA). Real-time
PCR was performed using Taqman primers for CSS1, CSS2,
CSS3, and serglycin (product numbers Hs00208704_m1,
Hs00226041_m1, Hs00545664_m1, and Hs01004159_m1 respec-
tively from Applied Biosystems, Foster City, CA). Gene expression
levels were measured by real time PCR using ABI Prism 7000
sequence detection system and normalized to GAPDH (Taqman
assay: Hs99999905_m1) using ABI Prism SDS 7000 software,
version 1.0 (Applied Biosystems). Each experiment was performed
in triplicate in a 25 ml reaction volume in TaqMan Universal PCR
Master Mix (Applied Biosystems). Each sample underwent initial
denaturation for 2 minutes at 50uC and then 10 minutes at 95uC,
followed by 40 cycles of denaturation at 95uC for 15 seconds and
combined primer annealing and extension at 60uC for 1 minute.
Statistics
Comparisons of several groups simultaneously were performed
by initially using analysis of variance (ANOVA). When the
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comparisons of each experimental group versus the control group
were performed using the Dunnett q’ statistic. Unless otherwise
indicated, summary statistics are reported as means 6 SEM, n=4.
Absent error bars in graphical displays of summary statistics
indicate SEM values smaller than the drawn symbols.
IRB approval
Detailed written informed consent was obtained from all
patients, following the Declaration of Helsinki protocols. These
studies were performed in accordance with a protocol that was
approved by the University of Pennsylvania Institutional Review
Board.
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